Structure-based three-dimensional pharmacophores as an alternative to traditional methodologies

A Gaurav, V Gautam - Journal of Receptor, Ligand and Channel …, 2014 - Taylor & Francis
Structure-based pharmacophore approaches have become widely used in drug discovery
and design. This can be attributed to the development of new tools and methods over the …

Identification of potential Akt activators: a ligand and structure-based computational approach

HB Kumar, S Manandhar, E Rathi, SP Kabekkodu… - Molecular Diversity, 2024 - Springer
The Akt pathway plays a significant role in various diseases like Alzheimer's, Parkinson's,
and Diabetes. Akt is the central protein whose phosphorylation controls many downstream …

Structural insights on vitamin D receptor and screening of new potent agonist molecules: structure and ligand-based approach

JM Jayaraj, E Reteti, C Kesavan… - Journal of Biomolecular …, 2021 - Taylor & Francis
Vitamin D deficiency is one of the common clinical symptoms of severe chronic kidney
disease (CKD) patients. Vitamin D receptor (VDR) is a part of the nuclear receptor family …

Identification of novel inhibitors against Mycobacterium tuberculosis L-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening

S Saxena, PB Devi, V Soni, P Yogeeswari… - Journal of Molecular …, 2014 - Elsevier
Mycobacterium tuberculosis (MTB) the etiological agent of tuberculosis (TB) survives in the
human host for decades evading the immune system in a latent or persistent state. The …

Vitamin D receptor-targeted treatment to prevent pathological dedifferentiation of pancreatic β cells under hyperglycaemic stress

AN John, Z Iqbal, S Colley, G Morahan… - Diabetes & …, 2018 - Elsevier
Dedifferentiation has been identified as one of the causes of β-cell failure resulting in type 2
diabetes (T2D). This study tested whether increasing vitamin D receptor (VDR) expression …

Mechanistic insights into the role of vitamin D and computational identification of potential lead compounds for Parkinson's disease

J John Marshal, BB Kuriakose… - Journal of Cellular …, 2023 - Wiley Online Library
Parkinson's disease (PD) is the second most common neurodegenerative disorder that
affects dopaminergic neurons in the midbrain. A recent study suggests that Orphan Nuclear …

Computational sampling and simulation based assessment of novel Mycobacterium tuberculosis glutamine synthetase inhibitors: Study involving structure based drug …

P Suryadevara, P Yogeeswari, V Soni… - Current topics in …, 2016 - ingentaconnect.com
The highly persistent nature of Mycobacterium tuberculosis can be attributed to its lipophilic
cell wall which acts as a major barrier in the process of drug discovery against tuberculosis …

Structural and functional insights on vitamin D receptor and CYP24A1 deleterious single nucleotide polymorphisms: A computational and pharmacogenomics …

JM Jayaraj, BB Kuriakose, AH Alhazmi… - Cell Biochemistry …, 2021 - Wiley Online Library
The development of chronic kidney disease (CKD) drugs remains a challenge due to the
variations in the genes. The vitamin D receptor (VDR) and Cytochrome 24A1 (CYP24A1) …

Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydratase

GO Petersen, S Saxena, J Renuka, V Soni… - Journal of Molecular …, 2015 - Elsevier
Dehydroquinate dehydratase (DHQase), the third enzyme of the shikimate pathway,
catalyzes the reversible reaction of 3-dehydroquinate into 3-dehydroshikimate. The aim of …

Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities

PB Devi, S Jogula, AP Reddy, S Saxena… - Molecular …, 2015 - Wiley Online Library
Pantothenate synthetase (PS) enzyme involved in the pantothenate biosynthetic pathway is
essential for the virulence and persistent growth of Mycobacterium tuberculosis (MTB). It is …